Pre-exposure prophylaxis and its implications in Mexico: notions of men who have sex with men

被引:3
作者
Baruch, R. [1 ]
Cuadra, S. M. [2 ]
Arellano, J. [3 ]
Sanchez, D. [4 ]
Ortega, D. V. [2 ]
Arredondo, A. [2 ]
机构
[1] Inst Nacl Salud Publ, Escuela Salud Publ Mexico, Ave Univ 655, Cuernavaca 62100, Morelos, Mexico
[2] Inst Nacl Salud Publ, Inst Nacl Salud Publ Mexico, Ctr Invest Sistemas Salud, Ave Univ 655, Cuernavaca 62100, Morelos, Mexico
[3] Coordinac Mexico, Programa Conjunto Nac Unidas VIH Sida, Homero 806,Colonia Polanco 6 Secc, Mexico City 11550, DF, Mexico
[4] Secretaria Relac Exteriores, Direcc Gen Org Nac Unidas, Ave Juarez, Mexico City 06000, DF, Mexico
关键词
HIV prevention; qualitative research; stigmatisation; COST-EFFECTIVENESS; HEALTH; INJECTION;
D O I
10.1071/SH18193
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The aim of this study was to analyse ideas regarding pre-exposure prophylaxis (PrEP) for the prevention of HIV among groups of men who have sex with men in Mexico for future implementation in health services. Methods: During 2015, 54 people participated in four focus groups in three Mexican cities. Issues related to challenges for uses and limitations of PrEP were explored. Results: In contrast with other qualitative studies, which emphasised problems with relationships with other people for PrEP use or access to key populations, Mexican participants focused their concerns around the public health services organisation: PrEP is too expensive and the health services have no resources, which will affect services and result in discrimination. Participants identified possible stigmatisation related to prejudices of medical providers who do not approve the decreased use of condoms. As a potential solution, participants suggested that the Mexican Government could negotiate a lower cost for PrEP and public health services could provide the medication, with periodical review of the arrangements by civil organisations. Conclusion: In the current context of the new Mexican government, it is necessary to propose public politics focused on negotiating with pharmaceutical companies on the costs of the PrEP, coordinating public services with groups within civil society and strengthening policies and actions to reduce stigma and discrimination.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 46 条
[1]   Acceptability of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Benin: a qualitative study [J].
Ahouada, Carin ;
Diabate, Souleymane ;
Gning, Ndeye Ndiagna ;
Hessou, Septime ;
Batona, Georges ;
Guedou, Fernand A. ;
Behanzin, Luc ;
Zannou, Marcel D. ;
Alary, Michel .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 (02) :242-248
[2]   Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence [J].
Amico, K. Rivet ;
Stirratt, Michael J. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 :S55-S60
[3]  
[Anonymous], NUEVA SUBSECRETARIA
[4]  
[Anonymous], 2006, SALUD PUBLICA MEXICO
[5]  
[Anonymous], 327 DENUNCIAS FALTA
[6]  
[Anonymous], 2019, GLOB PREP WATCH
[7]  
[Anonymous], 2012, Norma Oficial Mexicana NOM-253-SSA1-2012
[8]  
[Anonymous], POLICY BRIEF
[9]  
[Anonymous], VIG EP CAS VIH SIDA
[10]  
[Anonymous], ENC NAC INGR GAST HO